beta
RTRX
Retrophin, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.
Market Cap: 1.24 Billion
Primary Exchange: NASDAQ
Website: http://www.retrophin.com
Shares Outstanding: 51.1 Million
Float: 50.4 Million
Dividend: (%)
Beta: 0.9318351623733577
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1550 trading days
From: 2015-08-05 To: 2020-11-18
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|